International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 4 July-August 2024 Submit your research before last 3 days of August to publish your research paper in the issue of July-August.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 4
July-August 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

A Review on DMF Filing in EU, USA and Australia

Author(s) P. Shailaja, K. Sunil, V. Pushpalatha, G. Snehalatha, K. Satya Ashok
Country India
Abstract Drug master file (DMF) is highly confidential information describing the aspect elements and error free information regarding API and finished dosage form. It consists of two parts. One is open part and another one is restricted part. Open part contains the information about the quality of drug product by the licence holder. Prohibited part which is Closed part which is protect the secret and unofficial information about manufacturing of product which is relived In front of respect regulatory authorities. When two or more persons involved in manufacturing of pharmaceutical. The drug master file contains overall information about product quality, maturing stability and purity of the medicaments. Drug master file gives the support to the IND (Investigational New Drug) application, ANDA (Abbreviated New Drug Application), NDA. Every country has its own drug filling format and content. The current observation is different countries drug master filing, content of drug master filing and format of the filing respect countries.
Keywords API, IND, NDA, Investigational New Drug, Abbreviated New Drug Application, Drug Master File, DMF
Field Medical / Pharmacy
Published In Volume 4, Issue 5, September-October 2022
Published On 2022-09-03
Cite This A Review on DMF Filing in EU, USA and Australia - P. Shailaja, K. Sunil, V. Pushpalatha, G. Snehalatha, K. Satya Ashok - IJFMR Volume 4, Issue 5, September-October 2022. DOI 10.36948/ijfmr.2022.v04i05.009
DOI https://doi.org/10.36948/ijfmr.2022.v04i05.009
Short DOI https://doi.org/10/gqr494
View / Download PDF File

Share this


E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 4 Cover Page Vol 6 Isu 3 Cover Page Vol 6 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com